Vertex Stock Crashes On Pain Drug News; Is It Time To Sell Vertex Pharmaceuticals?
Vertex stock was already floundering even before Thursday when the company’s non-opioid pain drug underperformed expectations in a midstage study. Then investors hammered shares of Vertex Pharmaceuticals (VRTX). ↑ X NOW PLAYING How To Sell Stocks: When To Cut Losses The biotech stock plummeted as much as 15.6%, undercutting its 200-day line in huge volume,…
